Sign in
4

Changes in Ownership

Coherus Oncology, Inc. Filed Acc 0001567619-20-020096

Chief Operating Officer sold 22,770 shares at an average $17.72 ($403,510)

  • Chief Operating Officer acquired 6,783 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Anicetti Vincent R · Chief Operating Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2020-11-17 Exercise or conversion : show line 1 in the form +2,500 $2.50 $6,251 51,056 D
2020-11-17 Sale : show line 2 in the form −2,500 $17.50 $43,744 48,556 D
2020-11-17 Sale : show line 3 in the form −12,420 $17.68 $219,619 36,136 D
2020-11-17 Sale : show line 4 in the form −3,567 $17.68 $63,054 32,569 D
2020-11-18 Exercise or conversion : show line 5 in the form +4,283 $12.70 $54,394 36,852 D
2020-11-18 Sale : show line 6 in the form −4,283 $18.00 $77,094 32,569 D
Open-market sales · 22,770 sh · avg $17.72 · $403,510

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2020-11-17 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −2,500 7,488 D
2020-11-18 Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) −4,283 22,500 D
Loading xslF345X03/doc1.xml…